The company’s AI-builder approach with in-house AI innovation and bolt-on acquisitions will be key for its growth in the ...

Today's AI agents are a primitive approximation of what agents are meant to be. True agentic AI requires serious advances in reinforcement learning and complex memory.

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

A research team has developed a new way to measure and predict how plant leaves scatter and reflect light, revealing that ...

For all zodiac signs, 2026 will be a time of adaptation to changing conditions. Fire signs will more often feel the need to ...

Belgium is accelerating the EU’s ability to develop and deploy vaccine measures at speed because of its dense vaccine ecosystem ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

COO's revenues are showing strong growth as MyDay and MiSight drive momentum, while restructuring savings and buybacks ...

Licensed intrathecal gene therapy enhances treatment for Spinal Muscular Atrophy patients ...

While the shortest distance between two points is a straight line, a straight-line attack on a large language model isn't always the most efficient — and least noisy — way to get the LLM to do bad ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...